Pharma with ops in RTP lands potential $650M deal for multiple sclerosis drug
TG Therapeutics, which has operations in Morrisville, has secured a deal worth up to nearly $650 million to license its multiple sclerosis treatment outside of North America. Sales of the drop hit $16 million in the first full quarter of availability.
Read More
